TRVI Chart
See on advanced chart >
About
Trevi Therapeutics, Inc. were incorporated under the laws of the State of Delaware on March 17, 2011.Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious...
Read More
- HighlightA clinical-stage biopharmaceutical company that develops treatments for prurigo nodularis and chronic cough in adults with idiopathic pulmonary fibrosis
- ExchangeNASDAQ
- Listing Date05/07/2019
- Established Date03/17/2011
- Full-time Employees25
- Address195 Church Street 14th Floor New Haven Connecticut 06510
- Tel1-203-3042499
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Pharmaceuticals